Objectives. To examine the relationship between prostate size and the metho
d of cancer detection in men with organ-confined prostate cancer, and compa
re prostate size in men with and without cancer.
Methods. Prostate volume was evaluated in 720 men who had undergone radical
prostatectomy for Stage Tie or Stage T2 cancer. Men with Stage T2 cancer w
ere divided into those treated before 1989 (when widespread prostate-specif
ic antigen [PSA] testing began), or not. Gland volume was also examined in
265 men participating in the Baltimore Longitudinal Study of Aging who had
no clinical evidence of cancer. Volumes were compared using linear regressi
on to allow for age.
Results. Prostate volume in men with Stage Tie cancer was statistically sig
nificantly larger than in men with Stage T2 cancer diagnosed in the pre-PSA
era after adjusting for age (P = 0.0001), and statistically significantly
larger than in men without cancer above age 47 years based on 95% confidenc
e intervals. Prostate volumes in men with Stage T2 cancer diagnosed in the
pre-PSA era and in men without cancer were not statistically significantly
different.
Conclusions. Prostate volume in men with PSA-detected, organ-confined cance
r is larger than in men with palpable organ-confined cancer diagnosed in ei
ther the pre-PSA era or PSA era. These discrepancies may reflect a diagnost
ic bias due to the effect of benign prostatic hyperplasia on serum PSA that
results in the selection of men with larger prostates for biopsy. UROLOGY
56: 839-842, 2000. (C) 2000, Elsevier Science Inc.